Logo image of BTM

BITCOIN DEPOT INC (BTM) Stock Fundamental Analysis

NASDAQ:BTM - Nasdaq - US09174P1057 - Common Stock - Currency: USD

6.03  +0.4 (+7.1%)

After market: 5.86 -0.17 (-2.82%)

Fundamental Rating

4

Taking everything into account, BTM scores 4 out of 10 in our fundamental rating. BTM was compared to 83 industry peers in the Commercial Services & Supplies industry. Both the profitability and the financial health of BTM get a neutral evaluation. Nothing too spectacular is happening here. BTM has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year BTM has reported negative net income.
In the past year BTM had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: BTM reported negative net income in multiple years.
Each year in the past 5 years BTM had a positive operating cash flow.
BTM Yearly Net Income VS EBIT VS OCF VS FCFBTM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

The Return On Assets of BTM (-6.64%) is worse than 73.49% of its industry peers.
BTM has a Return On Invested Capital of 87.92%. This is amongst the best in the industry. BTM outperforms 100.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BTM is significantly above the industry average of 11.67%.
The 3 year average ROIC (74.55%) for BTM is below the current ROIC(87.92%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -6.64%
ROE N/A
ROIC 87.92%
ROA(3y)-15.14%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)74.55%
ROIC(5y)N/A
BTM Yearly ROA, ROE, ROICBTM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 50 100 150

1.3 Margins

BTM has a Operating Margin (8.00%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of BTM has grown nicely.
BTM has a Gross Margin of 19.01%. This is in the lower half of the industry: BTM underperforms 78.31% of its industry peers.
In the last couple of years the Gross Margin of BTM has grown nicely.
Industry RankSector Rank
OM 8%
PM (TTM) N/A
GM 19.01%
OM growth 3Y6.04%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.73%
GM growth 5YN/A
BTM Yearly Profit, Operating, Gross MarginsBTM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 5 10 15

5

2. Health

2.1 Basic Checks

BTM has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for BTM has been increased compared to 1 year ago.
Compared to 1 year ago, BTM has a worse debt to assets ratio.
BTM Yearly Shares OutstandingBTM Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M 20M
BTM Yearly Total Debt VS Total AssetsBTM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

BTM has an Altman-Z score of 10.06. This indicates that BTM is financially healthy and has little risk of bankruptcy at the moment.
BTM has a better Altman-Z score (10.06) than 92.77% of its industry peers.
The Debt to FCF ratio of BTM is 2.23, which is a good value as it means it would take BTM, 2.23 years of fcf income to pay off all of its debts.
BTM has a better Debt to FCF ratio (2.23) than 78.31% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 2.23
Altman-Z 10.06
ROIC/WACC7.62
WACC11.54%
BTM Yearly LT Debt VS Equity VS FCFBTM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 20M -20M 40M

2.3 Liquidity

BTM has a Current Ratio of 1.09. This is a normal value and indicates that BTM is financially healthy and should not expect problems in meeting its short term obligations.
BTM has a worse Current ratio (1.09) than 74.70% of its industry peers.
A Quick Ratio of 1.09 indicates that BTM should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.09, BTM is doing worse than 67.47% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.09
BTM Yearly Current Assets VS Current LiabilitesBTM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 10M 20M 30M 40M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 55.65% over the past year.
BTM shows a decrease in Revenue. In the last year, the revenue decreased by -9.72%.
Measured over the past years, BTM shows a small growth in Revenue. The Revenue has been growing by 1.48% on average per year.
EPS 1Y (TTM)55.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%180%
Revenue 1Y (TTM)-9.72%
Revenue growth 3Y1.48%
Revenue growth 5YN/A
Sales Q2Q%18.54%

3.2 Future

Based on estimates for the next years, BTM will show a very strong growth in Earnings Per Share. The EPS will grow by 71.36% on average per year.
BTM is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.26% yearly.
EPS Next Y174.37%
EPS Next 2Y71.36%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year10.33%
Revenue Next 2Y7.26%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BTM Yearly Revenue VS EstimatesBTM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M
BTM Yearly EPS VS EstimatesBTM Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 0 0.2 -0.2 0.4 -0.4

5

4. Valuation

4.1 Price/Earnings Ratio

BTM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 11.71 indicates a reasonable valuation of BTM.
Based on the Price/Forward Earnings ratio, BTM is valued a bit cheaper than the industry average as 79.52% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of BTM to the average of the S&P500 Index (22.19), we can say BTM is valued slightly cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 11.71
BTM Price Earnings VS Forward Price EarningsBTM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BTM is valued a bit cheaper than 79.52% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, BTM is valued a bit cheaper than the industry average as 74.70% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 14.43
EV/EBITDA 7.25
BTM Per share dataBTM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

BTM's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BTM's earnings are expected to grow with 71.36% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y71.36%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for BTM!.
Industry RankSector Rank
Dividend Yield N/A

BITCOIN DEPOT INC

NASDAQ:BTM (6/20/2025, 8:19:14 PM)

After market: 5.86 -0.17 (-2.82%)

6.03

+0.4 (+7.1%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)05-15 2025-05-15/bmo
Earnings (Next)N/A N/A
Inst Owners35.32%
Inst Owner Change47.15%
Ins Owners2.18%
Ins Owner Change98.02%
Market Cap387.79M
Analysts80
Price Target7.14 (18.41%)
Short Float %2.63%
Short Ratio0.36
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-408.8%
Min EPS beat(2)-931.68%
Max EPS beat(2)114.08%
EPS beat(4)1
Avg EPS beat(4)-774.08%
Min EPS beat(4)-1386.64%
Max EPS beat(4)114.08%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)5.11%
Min Revenue beat(2)3.02%
Max Revenue beat(2)7.2%
Revenue beat(4)3
Avg Revenue beat(4)4.44%
Min Revenue beat(4)-0.62%
Max Revenue beat(4)8.14%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)75.73%
PT rev (3m)49.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)22.73%
EPS NY rev (1m)9.46%
EPS NY rev (3m)76.09%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.09%
Revenue NY rev (1m)2.9%
Revenue NY rev (3m)3.92%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 11.71
P/S 0.65
P/FCF 14.43
P/OCF 10.36
P/B N/A
P/tB N/A
EV/EBITDA 7.25
EPS(TTM)-0.1
EYN/A
EPS(NY)0.52
Fwd EY8.54%
FCF(TTM)0.42
FCFY6.93%
OCF(TTM)0.58
OCFY9.66%
SpS9.32
BVpS-0.27
TBVpS-0.43
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.64%
ROE N/A
ROCE 100.31%
ROIC 87.92%
ROICexc 327.58%
ROICexgc 1943.2%
OM 8%
PM (TTM) N/A
GM 19.01%
FCFM 4.48%
ROA(3y)-15.14%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)74.55%
ROIC(5y)N/A
ROICexc(3y)871.35%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)85.05%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y59.71%
ROICexc growth 5YN/A
OM growth 3Y6.04%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.73%
GM growth 5YN/A
F-Score4
Asset Turnover6.68
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 2.23
Debt/EBITDA 0.84
Cap/Depr 117.24%
Cap/Sales 1.76%
Interest Coverage 4.37
Cash Conversion 65.75%
Profit Quality N/A
Current Ratio 1.09
Quick Ratio 1.09
Altman-Z 10.06
F-Score4
WACC11.54%
ROIC/WACC7.62
Cap/Depr(3y)37.6%
Cap/Depr(5y)47.02%
Cap/Sales(3y)0.68%
Cap/Sales(5y)0.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)55.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%180%
EPS Next Y174.37%
EPS Next 2Y71.36%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-9.72%
Revenue growth 3Y1.48%
Revenue growth 5YN/A
Sales Q2Q%18.54%
Revenue Next Year10.33%
Revenue Next 2Y7.26%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y59.28%
EBIT growth 3Y7.61%
EBIT growth 5YN/A
EBIT Next Year224.57%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-30.89%
FCF growth 3Y-8.41%
FCF growth 5YN/A
OCF growth 1Y-5.48%
OCF growth 3Y-1.07%
OCF growth 5YN/A